BCL2 and breast cancer: We therefore attempt to identify the molecular mechanisms governing this interplay, focusing our attention on MCL-1: the BCL-2 family anti-apoptotic member recently identified as involved in the control of cell invasion in several tumors, including breast cancer [30] and PDAC [31].